Kelsey Buran, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 |
Kimberley Monnet, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 248-635-2416 |
Mary Campbell, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 |
Suela Hysenaj, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 |
Gary Moelich, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 100 Hospital Drive, Bennington, VT 05201 Phone: 802-442-6361 |
Timothy Scott Snyder, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 |
Cody Holloway, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 530-640-0220 |
John Calvin Gower, CAA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-4535 Fax: 802-447-4537 |
News Archive
The University of Louisville has launched a research trial to study an investigational medical device designed to aid patients with emphysema by shutting off the diseased part of the lung. UofL is the only site in Kentucky among 14 nationwide testing the device.
Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.
Genzyme Corporation today announced that the company has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a potential new oral therapy for Gaucher disease type 1. The two multi-national, multi-center trials are being conducted to evaluate the safety and efficacy of the small molecule.
There are many good reasons to ensure sufficient exercise in everyday life. However, advising patients with increased blood pressure (hypertension) to exercise regularly is often regarded as a specific medical measure aiming to reduce the increased risk of late complications. But whether more exercise actually helps to avoid illnesses related to hypertension or at least delay their onset has been insufficiently investigated.
› Verified 1 days ago